Travere Therapeutics (TVTX) FCF Margin Growth (1y) (2015 - 2026)
Travere Therapeutics (TVTX) FCF Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | 1,989.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,989.00 |
| Dec 31, 2025 | 3,100.00 |
| Sep 30, 2025 | 10,245.00 |
| Jun 30, 2025 | 7,906.00 |
| Mar 31, 2025 | 23,576.00 |
| Dec 31, 2024 | 20,883.00 |
| Sep 30, 2024 | 9,243.00 |
| Jun 30, 2024 | 8,608.00 |
| Mar 31, 2024 | 3,403.00 |
| Dec 31, 2023 | -7,073.00 |
| Sep 30, 2023 | -1,861.00 |
| Jun 30, 2023 | -3,219.00 |
| Mar 31, 2023 | -8,457.00 |
| Dec 31, 2022 | -24,225.00 |
| Sep 30, 2022 | -18,732.00 |
| Jun 30, 2022 | -14,030.00 |
| Mar 31, 2022 | -17,152.00 |
| Dec 31, 2021 | 8,111.00 |
| Sep 30, 2021 | 3,803.00 |
| Jun 30, 2021 | 2,567.00 |